When most people think about cancer, they think of bad luck, lifestyle choices, or something that “just happens.” Very few ...

Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), a clinical-stage oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved antibody drug ...

On January 5, 2026, Genelux Corporation reported interim data from two ongoing trials of its oncolytic immunotherapy Olvi-Vec given intravenously to patients with progressive small cell and non-small ...

Cannabidiol (CBD), a non-intoxicating compound in marijuana, “holds substantial promise as an anti-tumor agent” in addition to its other anti-inflammatory properties, a new scientific review ...

Genelux Corporation (“Genelux”) (Nasdaq: GNLX), a late clinical-stage immuno-oncology company, today announced the pricing of an underwritten public offering of 6,666,667 shares of its common stock at ...

MS research suggests the disease may be divided into two biological subtypes that differ in how early and aggressively nerve ...

Advice for GPs on updated UK Medical Eligibility Criteria for Contraceptive use (UKMEC) which advises on safety of ...